ZA985018B - 9-oxime erythromycin derivatives. - Google Patents
9-oxime erythromycin derivatives.Info
- Publication number
- ZA985018B ZA985018B ZA9805018A ZA985018A ZA985018B ZA 985018 B ZA985018 B ZA 985018B ZA 9805018 A ZA9805018 A ZA 9805018A ZA 985018 A ZA985018 A ZA 985018A ZA 985018 B ZA985018 B ZA 985018B
- Authority
- ZA
- South Africa
- Prior art keywords
- erythromycin derivatives
- oxime erythromycin
- oxime
- derivatives
- erythromycin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4934997P | 1997-06-11 | 1997-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA985018B true ZA985018B (en) | 1999-12-10 |
Family
ID=21959341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9805018A ZA985018B (en) | 1997-06-11 | 1998-06-10 | 9-oxime erythromycin derivatives. |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0988308A1 (en) |
| JP (1) | JP2000513026A (en) |
| KR (1) | KR20010013660A (en) |
| CN (1) | CN1259135A (en) |
| AP (1) | AP9801253A0 (en) |
| AR (1) | AR012244A1 (en) |
| AU (1) | AU7226798A (en) |
| BG (1) | BG103947A (en) |
| BR (1) | BR9810021A (en) |
| CA (1) | CA2293335A1 (en) |
| CO (1) | CO4940506A1 (en) |
| CZ (1) | CZ9904388A3 (en) |
| EA (1) | EA199901016A1 (en) |
| GT (1) | GT199800074A (en) |
| HN (1) | HN1998000073A (en) |
| HR (1) | HRP980316A2 (en) |
| HU (1) | HUP0002252A3 (en) |
| ID (1) | ID24529A (en) |
| IL (1) | IL132767A0 (en) |
| IS (1) | IS5251A (en) |
| MA (1) | MA26505A1 (en) |
| NO (1) | NO996108L (en) |
| OA (1) | OA11225A (en) |
| PA (1) | PA8451801A1 (en) |
| PE (1) | PE79899A1 (en) |
| PL (1) | PL337606A1 (en) |
| TN (1) | TNSN98083A1 (en) |
| TR (1) | TR199902995T2 (en) |
| TW (1) | TW448174B (en) |
| WO (1) | WO1998056800A1 (en) |
| ZA (1) | ZA985018B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000159A (en) * | 1997-10-29 | 1999-02-09 | Monsanto Co | DERIVATIVES OF 9- AMINO - 3 CETO ERITROMICINA |
| EP1115732B1 (en) * | 1998-09-22 | 2005-06-29 | Pfizer Products Inc. | Carbamate and carbazate ketolide antibiotics |
| FR2786188B1 (en) * | 1998-11-24 | 2002-10-31 | Hoechst Marion Roussel Inc | NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
| US6258785B1 (en) | 1998-12-02 | 2001-07-10 | Pfizer Inc. | Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1-yl)propyl)hydrazono))-3-oxoerythromycin |
| EP1298138B1 (en) * | 1998-12-10 | 2006-11-02 | Pfizer Products Inc. | Carbamate and Carbazate Ketolide Antibiotics |
| US6284732B1 (en) * | 1998-12-18 | 2001-09-04 | Bio-Rad Laboratories, Inc. | Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases |
| AU773678B2 (en) * | 1999-04-16 | 2004-06-03 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| AP2001002302A0 (en) | 1999-05-24 | 2001-10-25 | Pfizer Prod Inc | 13-Methyl erythromycin derivatives. |
| PT1181300E (en) * | 1999-06-07 | 2004-02-27 | Abbott Lab | DERIVATIVES 6-O-CARBAMATE OF CETOLID |
| ID27331A (en) * | 1999-09-29 | 2001-03-29 | Pfizer Prod Inc | MAKING ANTIBIOTIC-ANTIBIOTIC KETOLIDA CARBAMATE |
| EP1439186A3 (en) * | 1999-12-29 | 2004-11-03 | Pfizer Products Inc. | Intermediates for novel antibacterial and prokinetic macrolides |
| EP1114826A3 (en) * | 1999-12-29 | 2001-10-31 | Pfizer Products Inc. | Novel antibacterial and prokinetic macrolides |
| US6946446B2 (en) | 2000-02-24 | 2005-09-20 | Abbott Laboratories | Anti-infective agents useful against multidrug-resistant strains of bacteria |
| US6403776B1 (en) | 2000-07-05 | 2002-06-11 | Pfizer Inc. | Synthesis of carbamate ketolide antibiotics |
| WO2003090761A1 (en) * | 2002-04-25 | 2003-11-06 | Abbott Laboratories | 9-oxime macrolide antibacterials |
| AR043050A1 (en) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | BIFunctional HETEROCICLICAL COMPOUNDS AND METHODS TO PREPARE AND USE THE SAME |
| EP1638549A4 (en) | 2003-03-10 | 2011-06-15 | Optimer Pharmaceuticals Inc | Novel antibacterial agents |
| WO2005085266A2 (en) | 2004-02-27 | 2005-09-15 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| AU2008316830B2 (en) | 2007-10-25 | 2016-03-17 | Cempra Pharmaceuticals, Inc. | Process for the preparation of macrolide antibacterial agents |
| JP5602748B2 (en) | 2008-10-24 | 2014-10-08 | センプラ ファーマシューティカルズ，インコーポレイテッド | Bioprotection using triazole-containing macrolides |
| US9937194B1 (en) | 2009-06-12 | 2018-04-10 | Cempra Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory diseases |
| CN102724874B (en) | 2009-09-10 | 2018-06-01 | 森普拉制药公司 | The method for treating malaria, tuberculosis and MAC diseases |
| CN102146085B (en) * | 2010-02-09 | 2014-03-26 | 北京理工大学 | 9-oxime-ether ketolide derivative, and preparation method and medical composite thereof |
| KR102006200B1 (en) | 2010-03-22 | 2019-08-01 | 셈프라 파마슈티컬스, 인크. | Crystalline forms of a macrolide, and uses therefor |
| ES2636948T3 (en) | 2010-05-20 | 2017-10-10 | Cempra Pharmaceuticals, Inc. | Processes for preparing macrolides and ketolides and intermediates for them |
| JP6042334B2 (en) | 2010-09-10 | 2016-12-14 | センプラ ファーマシューティカルズ，インコーポレイテッド | Hydrogen bond forming fluoroketolides for disease treatment |
| CA2868262A1 (en) | 2012-03-27 | 2013-10-03 | Cempra Pharmaceuticals, Inc. | Parenteral formulations for administering macrolide antibiotics |
| EP2968801B1 (en) | 2013-03-14 | 2018-09-26 | Cempra Pharmaceuticals, Inc. | Methods for treating respiratory diseases and formulations therefor |
| EP2968384A4 (en) | 2013-03-15 | 2017-02-15 | Cempra Pharmaceuticals, Inc. | Convergent processes for preparing macrolide antibacterial agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of erythromycin derivatives |
| US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2718450B1 (en) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | New erythromycin derivatives, their preparation process and their use as drugs. |
-
1998
- 1998-05-15 ID IDW991570A patent/ID24529A/en unknown
- 1998-05-15 CZ CZ19994388A patent/CZ9904388A3/en unknown
- 1998-05-15 CN CN98805848A patent/CN1259135A/en active Pending
- 1998-05-15 EP EP98919394A patent/EP0988308A1/en not_active Withdrawn
- 1998-05-15 KR KR1019997011672A patent/KR20010013660A/en not_active Application Discontinuation
- 1998-05-15 IL IL13276798A patent/IL132767A0/en unknown
- 1998-05-15 PL PL98337606A patent/PL337606A1/en unknown
- 1998-05-15 BR BR9810021-1A patent/BR9810021A/en not_active IP Right Cessation
- 1998-05-15 JP JP11501928A patent/JP2000513026A/en active Pending
- 1998-05-15 AU AU72267/98A patent/AU7226798A/en not_active Abandoned
- 1998-05-15 HU HU0002252A patent/HUP0002252A3/en unknown
- 1998-05-15 TR TR1999/02995T patent/TR199902995T2/en unknown
- 1998-05-15 WO PCT/IB1998/000741 patent/WO1998056800A1/en not_active Application Discontinuation
- 1998-05-15 EA EA199901016A patent/EA199901016A1/en unknown
- 1998-05-15 CA CA002293335A patent/CA2293335A1/en not_active Abandoned
- 1998-05-19 HN HN1998000073A patent/HN1998000073A/en unknown
- 1998-05-21 PA PA19988451801A patent/PA8451801A1/en unknown
- 1998-06-04 AP APAP/P/1998/001253A patent/AP9801253A0/en unknown
- 1998-06-05 GT GT199800074A patent/GT199800074A/en unknown
- 1998-06-08 PE PE1998000470A patent/PE79899A1/en not_active Application Discontinuation
- 1998-06-08 TW TW087109086A patent/TW448174B/en active
- 1998-06-09 AR ARP980102703A patent/AR012244A1/en unknown
- 1998-06-10 MA MA25105A patent/MA26505A1/en unknown
- 1998-06-10 ZA ZA9805018A patent/ZA985018B/en unknown
- 1998-06-10 TN TNTNSN98083A patent/TNSN98083A1/en unknown
- 1998-06-11 CO CO98033538A patent/CO4940506A1/en unknown
- 1998-06-11 HR HR60/049,349A patent/HRP980316A2/en not_active Application Discontinuation
-
1999
- 1999-11-16 IS IS5251A patent/IS5251A/en unknown
- 1999-12-03 BG BG103947A patent/BG103947A/en unknown
- 1999-12-03 OA OA9900269A patent/OA11225A/en unknown
- 1999-12-10 NO NO996108A patent/NO996108L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0988308A1 (en) | 2000-03-29 |
| BR9810021A (en) | 2000-09-19 |
| AU7226798A (en) | 1998-12-30 |
| TR199902995T2 (en) | 2000-02-21 |
| CN1259135A (en) | 2000-07-05 |
| NO996108D0 (en) | 1999-12-10 |
| HUP0002252A3 (en) | 2002-01-28 |
| HN1998000073A (en) | 1999-01-08 |
| AP9801253A0 (en) | 1999-12-04 |
| PL337606A1 (en) | 2000-08-28 |
| OA11225A (en) | 2003-07-17 |
| TW448174B (en) | 2001-08-01 |
| IS5251A (en) | 1999-11-16 |
| PA8451801A1 (en) | 2000-05-24 |
| NO996108L (en) | 2000-02-10 |
| PE79899A1 (en) | 1999-08-25 |
| BG103947A (en) | 2000-07-31 |
| IL132767A0 (en) | 2001-03-19 |
| AR012244A1 (en) | 2000-09-27 |
| WO1998056800A1 (en) | 1998-12-17 |
| HRP980316A2 (en) | 1999-04-30 |
| CA2293335A1 (en) | 1998-12-17 |
| GT199800074A (en) | 1999-11-27 |
| KR20010013660A (en) | 2001-02-26 |
| MA26505A1 (en) | 2004-12-20 |
| ID24529A (en) | 2000-07-20 |
| TNSN98083A1 (en) | 2005-03-15 |
| CO4940506A1 (en) | 2000-07-24 |
| EA199901016A1 (en) | 2000-06-26 |
| HUP0002252A2 (en) | 2000-12-28 |
| CZ9904388A3 (en) | 2002-10-16 |
| JP2000513026A (en) | 2000-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA985018B (en) | 9-oxime erythromycin derivatives. | |
| ZA9811940B (en) | Novel erythromycin derivatives. | |
| ZA9811939B (en) | Novel macrolides. | |
| PL348333A1 (en) | Macrolides | |
| AU9277698A (en) | 9-amino-3-keto erythromycin derivatives | |
| ZA98986B (en) | 3'-n-oxide,3'-N-dimethylamine, 9-oxime erythromycin A derivatives | |
| ZA200103289B (en) | Novel macrolide antibiotics. | |
| ZA9710648B (en) | Erythromycin A derivatives. | |
| ZA987688B (en) | 6,9-bridged erythromycin derivatives | |
| IL134996A0 (en) | 6,11-bridged erythromycin derivatives | |
| HUP0004282A3 (en) | 2-halo-6-0-substituted ketolide derivatives | |
| ZA200107346B (en) | Erythromycin derivatives. | |
| AU8925398A (en) | 3-descladinose 6-o-substituded erythromycin derivatives | |
| ZA983902B (en) | Erythromycin derivatives. | |
| EP1044985A4 (en) | Erythromycin derivatives | |
| ZA978546B (en) | Erythromycin A derivatives. | |
| MXPA99011001A (en) | Multicyclic erythromycin derivatives. | |
| ZA989848B (en) | 6,11-bridged erythromycin derivatives | |
| SI1015467T1 (en) | 6,9-bridged erythromycin derivatives | |
| SI1027361T1 (en) | 6,11-bridged erythromycin derivatives | |
| GB9700702D0 (en) | Erythromycin derivatives | |
| SI0966477T1 (en) | 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives | |
| ZA965692B (en) | Macrolides. | |
| ZA973362B (en) | Tricyclic erythromycin derivatives. | |
| ZA989845B (en) | 2-halo-6-O-substituted ketolide derivatives |